A preliminary study on the therapeutic efficacy of Duloxetine in the treatment of depersonalization-derealization disorder

doi:10.3969/j.issn.1006-7795.2023.04.012

Abstract

Abstract: Objective To explore the efficacy and influencing factors of Duloxetine in the treatment of depersonalization-derealization disorder (DPD). Methods The data were collected from January 2020 to December 2022 for DPD patients treated with Duloxetine at Beijing Anding Hospital, Capital Medical University. Survival analysis was used to analyze treatment efficacy and influencing factors. Results A total of 51 patients were included in this study, and 64.7% of the patients showed treatment efficacy. The median effective time was 118 (87, 643) days, and there was a trend of rapid improvement in emotional numbness symptoms. Education level was identified as a significant influencing factor for duloxetine treatment, with HR=0.81 (0.70, 0.95), P=0.008. Conclusions Duloxetine treatment for DPD, particularly for the patients with emotional numbness as the main complaint, has potential benefits and provides guidance for clinical treatment of DPD.

Key words: Duloxetine, depersonalization-derealization disorder, therapeutic efficacy

CLC Number:

Zheng Sisi, Song Mingkang, Song Nan, Zhu Hong, Jia Hongxiao. A preliminary study on the therapeutic efficacy of Duloxetine in the treatment of depersonalization-derealization disorder[J]. Journal of Capital Medical University, 2023, 44(4): 578-582.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2023.04.012

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2023/V44/I4/578

References

［1］ Yang J Y, Millman L S M, David A S, et al. The prevalence of depersonalization-derealization disorder: a systematic review［J］. J Trauma Dissociation, 2023, 24(1): 8-41.
［2］ Michal M, Adler J, Wiltink J, et al. A case series of 223 patients with depersonalization-derealization syndrome［J］. BMC Psychiatry, 2016, 16: 203.
［3］ Simeon D, Knutelska M, Putnam F W, et al. Attention and memory in depersonalization-spectrum dissociative disorders: impact of selective-divided attentional condition, stimulus emotionality, and stress［J］. J Trauma Dissociation, 2023, 24(1): 42-62.
［4］徐蕊, 杨敬铭, 朱虹, 等. 人格解体障碍病人的自我面孔识别速度的研究［J］. 首都医科大学学报, 2017, 38(2): 192-196.
［5］贾竑晓, 徐蕊, 朱虹, 等. 人格解体障碍的自我认知损害的神经心理学研究进展［J］. 国际精神病学杂志, 2016, 43(1): 50-54.
［6］宋楠, 贾竑晓. 人格解体患者认知功能及与临床症状和社会功能的相关性［J］. 首都医科大学学报, 2020, 41(1): 59-63.
［7］ Hunter E C M, Charlton J, David A S. Depersonalisation and derealisation: assessment and management［J］. BMJ, 2017, 356: j745.
［8］ Sierra M. Depersonalization disorder: pharmacological approaches［J］. Expert Rev Neurother, 2008, 8(1): 19-26.
［9］ Simeon D, Guralnik O, Knutelska M, et al. Basal norepinephrine in depersonalization disorder［J］. Psychiatry Res, 2003, 121(1): 93-97.
［10］ American Psychiatric Association, American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5［M］. 5th ed. Washington, D.C.: American Psychiatric Association, 2013:302.
［11］ Jay E L, Sierra M, Van Den Eynde F, et al. Testing a neurobiological model of depersonalization disorder using repetitive transcranial magnetic stimulation［J］. Brain Stimul, 2014, 7(2): 252-259.
［12］ Simeon D, Kozin D S, Segal K, et al. De-constructing depersonalization: further evidence for symptom clusters［J］. Psychiatry Res, 2008, 157(1/3): 303-306.
［13］ Segal S K, Cahill L. Endogenous noradrenergic activation and memory for emotional material in men and women［J］. Psychoneuroendocrinology, 2009, 34(9): 1263-1271.
［14］ Montagrin A, Sander D. Emotional memory: from affective relevance to arousal［J］. Behav Brain Sci, 2016, 39: e216.
［15］ Segal S K, Stark S M, Kattan D, et al. Norepinephrine-mediated emotional arousal facilitates subsequent pattern separation［J］. Neurobiol Learn Mem, 2012, 97(4): 465-469.

[1]	Liu Genliang, Yu Zhenwei, Feng Tao. Erythrocytic alpha-synuclein in early-onset Parkinsons disease and the clinical application [J]. Journal of Capital Medical University, 2023, 44(5): 782-787.
[2]	Huo Yuan, Qu Yan, Li Xiaohong. Research progress on non-pharmacological therapy of freezing of gait in Parkinson’s disease [J]. Journal of Capital Medical University, 2023, 44(5): 803-810.
[3]	Hu Zhengfang, Wang Juan, Jian Minyu, Han Ruquan. ffect of intraoperative oxygen concentration on postoperative neurological function and complications in patients undergoing cerebrovascular recanalization [J]. Journal of Capital Medical University, 2023, 44(5): 865-871.
[4]	Wang Rongliang, Yan Feng, Tian yue, Huang Yuyou, Luo Yumin, Ma Shubei. Effects of Pioglitazone on neuronal damage in the mouse hippocampus after middle cerebral artery occlusion and reperfusion [J]. Journal of Capital Medical University, 2023, 44(4): 645-651.
[5]	Li Xue, Feng Zhengtian, Zheng Sisi, Duan Yuhang, Wu Ziyao, Zhu Hong, Jia Hongxiao. Network analysis of mental and physical symptoms in patients with generalized anxiety disorder [J]. Journal of Capital Medical University, 2023, 44(4): 568-577.
[6]	Song Mingkang, Xu Tianchao, Jia Hongxiao, Li Dongdong, Zheng Sisi, Yin Dongqing, Li Xue. Exploration of traditional Chinese medicine syndrome discipline of panic disorder based on Cluster analysis and Bayesian network [J]. Journal of Capital Medical University, 2023, 44(4): 583-589.
[7]	Zhong Jie, Zhu Hong, Hao Jun, Jia Hongxiao. The mediating effect of theory of mind between psychotic symptoms and social functioning in stable schizophrenia [J]. Journal of Capital Medical University, 2023, 44(4): 590-595.
[8]	Zhong Jie, Zhu Hong, Zheng Sisi, Jia Hongxiao. Predictive role of machine-learning-based theory of mind in acute phase schizophrenia on social functioning [J]. Journal of Capital Medical University, 2023, 44(4): 596-601.
[9]	Yan Aiguo, Liu Xinzi, Yin Dongqing, Zhu Hong , Jia Hongxiao , Li Ziyan. Psychosocial characteristics associated with relapse of bipolar disorder [J]. Journal of Capital Medical University, 2023, 44(4): 602-608.
[10]	Yang Jingming, Wang Xin, Liu Ligai, Hao Yiwei, Song Rui, Jia Hongxiao. Correlationship between anxiety trait and mental health in patients with severe acute respiratory syndrome coronavirus [J]. Journal of Capital Medical University, 2023, 44(4): 609-613.
[11]	Wang Qunsong, Yu Haiyan, Ji Xiangdong, Li Miao, Jiang Yiye. Intervention effect of electroacupuncture on metabolic syndrome induced by new antipsychotics [J]. Journal of Capital Medical University, 2023, 44(4): 614-619.
[12]	Zhao Huiqing, Zhang Yaqing. Investigation and analysis of migraine diagnosis and treatment in general practitioners [J]. Journal of Capital Medical University, 2023, 44(3): 482-486.
[13]	Hu Shuyuan, Zhang Kaiyuan, Gu Yaqin, Li Jingka, Zhou Chen, Ji Xunming, Duan Jiangang. Exploration of glucocorticoid combined with anticoagulation in acute/subacute severe cerebral venous thrombosis [J]. Journal of Capital Medical University, 2023, 44(2): 280-288.
[14]	Liang Fa, Wu Youxuan, Wang Xinyan, Jian Minyu, Liu Haiyang, Han Ruquan. Effects of emergency conversion to general anesthesia on neurological outcomes of patients with acute ischemic stroke undergoing mechanical thrombectomy [J]. Journal of Capital Medical University, 0, (): 237-243.
[15]	Li Qiong, Zhao Jianhua, Liu Hao, Wang Fan, Li Qing, Chen Xiyan, Cai Ruiyan, Wu Qingwu, Zhang Jian, Ji Sibei, Lu Chengbiao, Li Shaomin. The relationship between serum CX3CL1 level and cognitive dysfunction in patients with white matter hyperintensity [J]. Journal of Capital Medical University, 2023, 44(1): 6-12.